Ceres signs contract with Shell for green hydrogen
Contract to design a 10MW pressurised solid oxide electrolyser (“SOEC”) module to produce green hydrogen at 36kWh/kg Builds on the data being generated from... Read more.
Boku Connects Poland’s 16.3m BLIK Users Into Google With New Payment Relationship
LONDON–(BUSINESS WIRE)–Boku Inc. (LON: BOKU), the global network for localized payment solutions, is pleased to announce that it now supports BLIK, the... Read more.
Marqeta Expands Partnership with Lydia to Power New European Digital Bank Sumeria
Sumeria marks a new chapter for Lydia, creating a highly customized digital banking experience for customers across Europe AMSTERDAM–(BUSINESS WIRE)–Marqeta... Read more.
Marqeta Announces New European Leader, Sees Rising Demand for Embedded Finance Offerings and New Customer Launches
The company named PayPal veteran Marcin Glogowski as SVP, Managing Director Europe and UK CEO, responsible for leading Marqeta in the region. As Marqeta experiences... Read more.
GenSight Biologics to Present at Upcoming Medical Conferences and Stakeholder Meetings
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing... Read more.
Philip Morris International Presents at 2024 Deutsche Bank Global Consumer Conference
Raises, for Currency Only, 2024 Full-Year Reported and Adjusted Diluted EPS Forecast, While Reaffirming Currency-Neutral Adjusted Diluted EPS Growth Forecast of... Read more.
HAFNIA LIMITED: Exercise of Options by a Primary Insider
SINGAPORE–(BUSINESS WIRE)–On 3 June 2024, Mikael Skov, CEO and primary insider of Hafnia Limited (“Hafnia”, the “Company”, OSE... Read more.
1Password Strengthens EMEA Presence with Significant Business Growth, Key Customer Wins, and Region-Specific Product Capabilities
The company expands its regional footprint, secures major customers and partners, and accelerates team growth TORONTO–(BUSINESS WIRE)–1Password, a leader... Read more.
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides
In heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression... Read more.
BenevolentAI to participate in Goldman Sachs 45th Annual Global Healthcare Conference
LONDON–(BUSINESS WIRE)–BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced... Read more.